Understanding Omeprazole Treatment Guidelines
BNF Dosage Recommendations for Omeprazole
According to the British National Formulary, omeprazole 20mg once daily represents the standard initial dose for gastro-oesophageal reflux disease (GORD) and dyspepsia. The BNF recommends taking omeprazole capsules whole, preferably before food, to optimise acid suppression. Treatment duration typically ranges from 4-8 weeks for initial therapy, though maintenance treatment may be appropriate for severe cases.
Clinical Indications and Treatment Options
Omeprazole effectively treats various acid-related conditions including peptic ulcer disease, erosive oesophagitis, and Helicobacter pylori eradication when combined with appropriate antibiotics. EverydayMeds stocks omeprazole 20mg capsules alongside branded Losec MUPS tablets, providing flexibility for patients who may prefer different formulations. The BNF emphasises reviewing long-term PPI therapy regularly to ensure continued clinical benefit.
Alternative Proton Pump Inhibitors
When omeprazole proves unsuitable, alternative PPIs may be considered. Lansoprazole 15mg capsules offer similar efficacy with potentially different tolerability profiles, whilst pantoprazole 20mg tablets may suit patients experiencing specific side effects with omeprazole. Esomeprazole represents the S-isomer of omeprazole and may provide enhanced acid control in certain individuals. EverydayMeds maintains comprehensive stock of these alternatives to support personalised treatment approaches.
H2 Receptor Antagonists as Alternatives
For patients unable to tolerate PPIs or requiring step-down therapy, famotidine tablets offer effective acid reduction through H2 receptor antagonism. This medication works differently to omeprazole by blocking histamine receptors rather than proton pumps, potentially reducing concerns about long-term PPI usage whilst maintaining symptom control for appropriate patients.
